<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormalities in the thyroid function and thyroid autoantibodies have been frequently described in patients with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> but seldom in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> patients </plain></SENT>
<SENT sid="1" pm="."><plain>In order to determine the prevalence of thyroid function and autoimmune abnormalities, we compared serum thyrotropin (TSH, serum free <z:chebi fb="4" ids="30660">thyroxine</z:chebi> (T4) levels, thyroid antithyroglobulin (TgAb) and antithyroperoxidase (TPOAb) levels of 25 patients with systemic <z:mp ids='MP_0000612'>sclerosis</z:mp>, 25 patients with <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> and 13 patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> to a control group of 113 healthy individuals </plain></SENT>
<SENT sid="2" pm="."><plain>Evaluation included a thorough clinical examination with particular attention to <z:hpo ids='HP_0000820'>thyroid disease</z:hpo> and a serologic immune profile including rheumatoid factor, antinuclear and anticardiolipin antibody measurements </plain></SENT>
<SENT sid="3" pm="."><plain>Subclinical <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo> (4.2&lt;TSH&lt;10 mU/L) was diagnosed in five patients (8%), and subclinical <z:hpo ids='HP_0000836'>hyperthyroidism</z:hpo> (undetectable&lt;TSH&lt;0.34 mU/L) in four patients (6%) </plain></SENT>
<SENT sid="4" pm="."><plain>Anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase (tPOAb) antibodies were present in 21/63 (33%) of our patients: 13/25 (52%) of the systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> cases, 8/25 (32%) of the <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> patients, but 0 (0/13) of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>In conclusion, our data confirm a high prevalence of silent autoimmune <z:hpo ids='HP_0000820'>thyroid diseases</z:hpo> in association with systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> and <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (p&lt;0.02), but not with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Elevated antibody titres may reflect an epiphenomenon of the underlying <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> and play an additive role in the development of the <z:e sem="disease" ids="C0015190" disease_type="Disease or Syndrome" abbrv="">euthyroid sick syndrome</z:e> in these patients, but our data suggest that the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> presents a different pattern of response </plain></SENT>
<SENT sid="7" pm="."><plain>Subclinical <z:hpo ids='HP_0000820'>thyroid diseases</z:hpo> should be considered when evaluating patients with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
</text></document>